ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 219 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,011,784 | -22.5% | 84,482 | +0.2% | 0.01% | -22.2% |
| Q2 2023 | $3,887,928 | +10.6% | 84,282 | -3.9% | 0.01% | +12.5% |
| Q1 2023 | $3,515,687 | -13.4% | 87,673 | 0.0% | 0.01% | -20.0% |
| Q4 2022 | $4,061,890 | +8.1% | 87,673 | -3.4% | 0.01% | 0.0% |
| Q3 2022 | $3,756,000 | -30.6% | 90,713 | 0.0% | 0.01% | -23.1% |
| Q2 2022 | $5,412,000 | -12.9% | 90,713 | +6.0% | 0.01% | +8.3% |
| Q1 2022 | $6,213,000 | -14.7% | 85,551 | -1.3% | 0.01% | -7.7% |
| Q4 2021 | $7,287,000 | -6.3% | 86,652 | +0.5% | 0.01% | -13.3% |
| Q3 2021 | $7,776,000 | -7.6% | 86,213 | -2.3% | 0.02% | -6.2% |
| Q2 2021 | $8,415,000 | +207.7% | 88,253 | +267.3% | 0.02% | +220.0% |
| Q1 2021 | $2,735,000 | -23.6% | 24,025 | -7.0% | 0.01% | -28.6% |
| Q4 2020 | $3,578,000 | +50.6% | 25,845 | -10.6% | 0.01% | +40.0% |
| Q3 2020 | $2,376,000 | +7.2% | 28,905 | +2.0% | 0.01% | 0.0% |
| Q2 2020 | $2,216,000 | +72.7% | 28,325 | -1.9% | 0.01% | +25.0% |
| Q1 2020 | $1,283,000 | +4.0% | 28,885 | 0.0% | 0.00% | +33.3% |
| Q4 2019 | $1,234,000 | -0.6% | 28,885 | -0.5% | 0.00% | 0.0% |
| Q3 2019 | $1,242,000 | -32.6% | 29,035 | 0.0% | 0.00% | -40.0% |
| Q2 2019 | $1,844,000 | +0.5% | 29,035 | +9.8% | 0.01% | 0.0% |
| Q1 2019 | $1,834,000 | +59.6% | 26,435 | 0.0% | 0.01% | +66.7% |
| Q4 2018 | $1,149,000 | -42.8% | 26,435 | +0.4% | 0.00% | -40.0% |
| Q3 2018 | $2,009,000 | -0.7% | 26,319 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $2,023,000 | +57.3% | 26,319 | +4.4% | 0.01% | +25.0% |
| Q1 2018 | $1,286,000 | +10.6% | 25,219 | +0.5% | 0.00% | +33.3% |
| Q4 2017 | $1,163,000 | -10.2% | 25,082 | +3.1% | 0.00% | -25.0% |
| Q3 2017 | $1,295,000 | -14.3% | 24,322 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,511,000 | -8.4% | 24,322 | 0.0% | 0.00% | -20.0% |
| Q1 2017 | $1,649,000 | -3.6% | 24,322 | 0.0% | 0.01% | 0.0% |
| Q4 2016 | $1,710,000 | -0.9% | 24,322 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $1,725,000 | +44.8% | 24,322 | -0.1% | 0.01% | +25.0% |
| Q2 2016 | $1,191,000 | -18.3% | 24,342 | +5.8% | 0.00% | -33.3% |
| Q1 2016 | $1,457,000 | -41.0% | 23,007 | +4.5% | 0.01% | -33.3% |
| Q4 2015 | $2,469,000 | +24.3% | 22,007 | +6.7% | 0.01% | +12.5% |
| Q3 2015 | $1,986,000 | +262.4% | 20,617 | +285.3% | 0.01% | +300.0% |
| Q2 2015 | $548,000 | – | 5,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |